Sun Mohan, Luo Zhiqiang, Liu Yang, Yang Ruirui, Lu Lina, Yu Guohua, Ma Xiaoyun, Liu Aoxue, Guo Yafang, Zhao Haiyu
School of Chinese Materia Medica, Beijing Univ. of Chinese Medicine, Beijing, P.R. China.
Inst. of Chinese Materia Medica, China Acad. of Chinese Medical Sciences, Beijing, P.R. China.
J Food Sci. 2016 Oct;81(10):H2587-H2596. doi: 10.1111/1750-3841.13435. Epub 2016 Sep 7.
Buddleja officinalis Maxim, one of the most popular herbal medicines in China, is widely prescribed for curing eye diseases for centuries. In this study, the major components of B. officinalis extract (BOE) and their metabolites in rat urine were detected and identified by ultra-high-pressure liquid chromatography coupled with linear ion trap-orbitrap tandem mass spectrometry (UHPLC-LTQ-Orbitrap). A total of 19 compounds, including 8 flavonoids and 11 phenylethanoid glycosides, were confirmed or tentatively identified from BOE. In vivo, 33 components, including 3 prototypes and 30 metabolies, were confirmed or tentatively identified in rat urine samples. The metabolic pathways of different types of compounds were also proposed. This study would effectively narrow the range of potentially bioactive constituents of BOE and shed light to its action mechanism.
密蒙花是中国最常用的草药之一,几个世纪以来一直被广泛用于治疗眼部疾病。在本研究中,采用超高压液相色谱-线性离子阱-轨道阱串联质谱法(UHPLC-LTQ-Orbitrap)对密蒙花提取物(BOE)中的主要成分及其在大鼠尿液中的代谢产物进行了检测和鉴定。从BOE中总共确认或初步鉴定出19种化合物,包括8种黄酮类化合物和11种苯乙醇苷。在体内实验中,在大鼠尿液样本中确认或初步鉴定出33种成分,包括3种原型成分和30种代谢产物。还提出了不同类型化合物的代谢途径。本研究将有效缩小BOE潜在生物活性成分的范围,并为其作用机制提供线索。